Central Pharmaceuticals Ltd.

Equities

CENTRALPHL

BD0487CPL007

End-of-day quote Dhaka S.E. Other stock markets 06:00:00 2024-05-22 pm EDT			5-day change	1st Jan Change
18.2 ^BDT	-2.67%		-10.34%	-9.90%

Mar. 11	Central Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	CI
2023	Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2017

January 30, 2018

Central Pharmaceuticals Ltd. announced unaudited earnings results for the second quarter and six months ended December 31, 2017. For the quarter, EPS was BDT 0.02 against BDT 0.56 a year ago. For the six months, EPS was BDT 0.15 against BDT 0.66 a year ago. NOCFPS was BDT 0.02 against BDT 0.09 a year ago. NAV per share was BDT 15.41 as on December 31, 2017.

Latest news about Central Pharmaceuticals Ltd.

Central Pharmaceuticals Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	Mar. 11	CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2023	Dec. 28	CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the First Quarter Ended September 30, 2022	23-01-01	CI
Central Pharmaceuticals Ltd. Auditor Raises 'Going Concern' Doubt	22-11-02	CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Full Year Ended June 30, 2021	22-01-11	CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2020	20-11-05	CI
Central Pharmaceuticals Ltd. Restates Earnings Results for the Period from January-March 2020 and for the Period from July 2019-March 2020	20-10-06	CI
Central Pharmaceuticals Ltd. Recommends 1% Cash Dividend for the Year Ended on June 30, 2019	19-11-04	CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2019	19-11-04	CI
CENTRALPHL Announces Demise of Nashima Akhter, Director on May 18, 2018	19-01-22	CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2018	18-05-03	CI
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2017	18-01-30	CI
Central Pharmaceuticals Ltd. Announces Unaudited Earnings Results for the First Quarter Ended September 2017	17-11-14	CI
Central Pharmaceuticals Ltd. Reports Earnings Results for the Year Ended June 30, 2017	17-10-28	CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2017	17-05-01	CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2016	17-01-24	CI
Central Pharmaceuticals Ltd. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2016	16-11-14	CI
31,105,000 Ordinary Shares of Central Pharmaceuticals Ltd. are subject to a Lock-Up Agreement Ending on 26-JUN-2016.	16-06-25	CI
16,895,000 Ordinary Shares of Central Pharmaceuticals Ltd. are subject to a Lock-Up Agreement Ending on 26-JUN-2014.	14-06-25	CI
Central Pharmaceuticals Ltd. has completed an IPO in the amount of BDT 140 million.	13-06-27	CI
Central Pharmaceuticals Ltd. has filed an IPO in the amount of BDT 140 million.	13-03-27	CI

Chart Central Pharmaceuticals Ltd.

Duration

Period

More charts

Company Profile

Sector

More about the company

Income Statement Evolution

More financial data